4.2 Article

General dental practitioners' perceptions of antimicrobial use and resistance: a qualitative interview study

Journal

BRITISH DENTAL JOURNAL
Volume 217, Issue 5, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/sj.bdj.2014.761

Keywords

-

Funding

  1. Wales School for Primary Care Research [504, 746]
  2. Cardiff University [RCUC099]

Ask authors/readers for more resources

Background Dentists are responsible for 9-10% of all antibiotics dispensed in primary care in the UK, many of which may be provided contrary to clinical guidelines. Since antibiotic consumption has been identified as a major cause of antibiotic resistance, dental prescribing may be a significant contributor to this important public health problem. Objective This study aims to explore general dental practitioners' (GDPs) perceptions and attitudes towards antibiotic use and resistance. Method Qualitative interview study with 19 purposively sampled GDPs working in Wales. A set of open-ended questions were developed and amended during semi-structured telephone interviews. Interviews were recorded, transcribed verbatim and codes were developed using thematic analysis. Results Perceptions of antibiotic use and resistance varied widely between practitioners, particularly with respect to the prevalence and impact of resistant strains on the management of dentoalveolar infection, and the impact of dental prescribing on the emergence of resistance. GDPs reported that their antibiotic prescribing decisions were driven by both clinical pressures and wider public health considerations. Conclusions Interventions to enhance the quality of antibiotic prescribing in primary care dentistry should address issues associated with inappropriate prescribing as well as providing education about the causes, prevalence and impact of antibiotic resistance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Public, Environmental & Occupational Health

Between- and Within-Individual Sociodemographic and Psychological Determinants of PrEP Adherence Among Men Who have Sex with Men Prescribed a Daily PrEP Regimen in Wales

David Gillespie, Marijn de Bruin, Dyfrig A. Hughes, Richard Ma, Adam Williams, Fiona Wood, Zoe Couzens, Adam Jones, Kerenza Hood

Summary: This study investigated the factors influencing the use of PrEP and the coverage of condomless anal sex (CAS) by PrEP among men who have sex with men in Wales, UK. The results showed that an STI diagnosis was associated with lower PrEP use and coverage, while older adults had higher PrEP use. Believing that other PrEP users took PrEP as prescribed was associated with lower PrEP coverage. These findings suggest that an STI diagnosis can be an important cue for interventions to improve PrEP coverage, and provide a basis for developing evidence-informed interventions to promote PrEP coverage.

AIDS AND BEHAVIOR (2023)

Article Economics

Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries

Xiao Li, Joke Bilcke, Alike W. van der Velden, Robin Bruyndonckx, Samuel Coenen, Emily Bongard, Muirrean de Paor, Slawomir Chlabicz, Maciek Godycki-Cwirko, Nick Francis, Rune Aabenhus, Heiner C. Bucher, Annelies Colliers, An De Sutter, Ana Garcia-Sangenis, Dominik Glinz, Nicolay J. Harbin, Katarzyna Kosiek, Morten Lindbaek, Christos Lionis, Carl Llor, Reka Miko-Pauer, Ruta Radzeviciene Jurgute, Bohumil Seifert, Par-Daniel Sundvall, Pia Touboul Lundgren, Nikolaos Tsakountakis, Theo J. Verheij, Herman Goossens, Christopher C. Butler, Philippe Beutels

Summary: This study aimed to evaluate the cost-effectiveness of adding oseltamivir to primary care in Europe for treating influenza-like illness (ILI) in adults/adolescents and children. The results showed that adding oseltamivir to primary care is likely to be cost-effective from the healthcare payers' perspective, and cost-saving from a societal perspective in adults/adolescents.

EUROPEAN JOURNAL OF HEALTH ECONOMICS (2023)

Article Dermatology

Long-term oral antibiotic use in people with acne vulgaris in UK primary care: a drug utilization study

Ketaki Bhate, Kathryn E. Mansfield, Sarah-Jo Sinnott, David J. Margolis, Elizabeth Adesanya, Nick Francis, Clemence Leyrat, Susan Hopkins, Richard Stabler, Laura Shallcross, Sinead M. Langan, Rohini Mathur

Summary: This study investigated the use of oral antibiotics for moderate-to-severe acne vulgaris using primary care data. It was found that 44.5% of individuals received long-term oral antibiotic treatment, with a median of four continuous courses per person. Further research is needed to understand the consequences of using antibiotics for shorter periods.

BRITISH JOURNAL OF DERMATOLOGY (2023)

Article Primary Health Care

Post-consultation acute respiratory tract infection recovery: a latent class-informed analysis of individual patient data

Hilda Hounkpatin, Beth Stuart, Shihua Zhu, Guiqing Yao, Michael Moore, Christin Loeffler, Paul Little, Timothy Kenealy, David Gillespie, Nick A. Francis, Jennifer Bostock, Taeko Becque, Bruce Arroll, Attila Altiner, Pablo Alonso-Coello, Alastair D. Hay

Summary: This study analyzed data from 12 primary care studies involving 9103 adults and children, and found that 90% of participants recovered from all symptoms within 28 days, regardless of antibiotic use. For respiratory tract infections with cough as the dominant symptom, four different symptom trajectories were identified, including rapid recovery, intermediate recovery, slow progressive improvement, and slow improvement with initial high symptom burden. Patients with longer duration of cough symptoms were more likely to have re-consultations and hospital admissions.

BRITISH JOURNAL OF GENERAL PRACTICE (2023)

Article Medicine, General & Internal

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Christopher C. Butler, F. D. Richard Hobbs, Oghenekome A. Gbinigie, Najib M. Rahman, Gail Hayward, Duncan B. Richards, Jienchi Dorward, David M. Lowe, Joseph F. Standing, Judith Breuer, Saye Khoo, Stavros Petrou, Kerenza Hood, Jonathan S. Nguyen-Van-Tam, Mahendra G. Patel, Benjamin R. Saville, Joe Marion, Emma Ogburn, Julie Allen, Heather Rutter, Nick Francis, Nicholas P. B. Thomas, Philip Evans, Melissa Dobson, Tracie-Ann Madden, Jane Holmes, Victoria Harris, May Ee Png, Mark Lown, Oliver van Hecke, Michelle A. Detry, Christina T. Saunders, Mark Fitzgerald, Nicholas S. Berry, Lazaro Mwandigha, Ushma Galal, Sam Mort, Bhautesh D. Jani, Nigel D. Hart, Haroon Ahmed, Daniel Butler, Micheal McKenna, Jem Chalk, Layla Lavallee, Elizabeth Hadley, Lucy Cureton, Magdalena Benysek, Monique Andersson, Maria Coates, Sarah Barrett, Clare Bateman, Jennifer C. Davies, Ivy Raymundo-Wood, Andrew Ustianowski, Andrew Carson-Stevens, Ly-Mee Yu, Paul Little

Summary: This study aimed to determine the safety, effectiveness, and cost-effectiveness of molnupiravir in vaccinated high-risk patients in the community. The results showed that molnupiravir did not reduce hospital admissions or deaths associated with COVID-19 compared to usual care in this population.

LANCET (2023)

Article Public, Environmental & Occupational Health

Non-pharmaceutical interventions and risk of COVID-19 infection: survey of UK public from November 2020-May 2021

Nick A. A. Francis, Taeko Becque, Merlin Willcox, Alastair D. D. Hay, Mark Lown, Richard Clarke, Beth Stuart, Lucy Yardley, Michael Moore, Joelle Houriet, Paul Little

Summary: This study found that non-pharmaceutical interventions such as wearing face masks, practicing social distancing, and frequent handwashing have strong protective effects against COVID-19 infection.

BMC PUBLIC HEALTH (2023)

Article Primary Health Care

Predicting illness progression for children with lower respiratory infections in primary care: a prospective cohort and observational study

Paul Little, Taeko Becque, Alastair D. Hay, Nick A. Francis, Beth Stuart, Gilly O'Reilly, Natalie Thompson, Kerenza Hood, Michael Moore, Theo Verheij

Summary: This study externally validated an existing prognostic model for children with lower respiratory tract infections (LRTIs) and developed a new model for internal validation. The study found that a simple three-item prognostic score could effectively identify children with LRTI who are at low risk of adverse outcomes, providing guidance for clinical management.

BRITISH JOURNAL OF GENERAL PRACTICE (2023)

Article Medicine, General & Internal

Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial

Miriam Santer, Megan Lawrence, Susanne Renz, Zina Eminton, Beth Stuart, Tracey H. Sach, Sarah Pyne, Matthew J. Ridd, Nick Francis, Irene Soulsby, Karen Thomas, Natalia Permyakova, Paul Little, Ingrid Muller, Jacqui Nuttall, Gareth Griffiths, Kim S. Thomas, Alison M. Layton

Summary: This study assessed the effectiveness of oral spironolactone for acne vulgaris in adult women. The results showed that spironolactone had significant improvement in acne symptoms and quality of life compared to placebo at 12 weeks and 24 weeks, with no serious adverse reactions reported. This suggests that spironolactone is a useful alternative to oral antibiotics for women with acne.

BMJ-BRITISH MEDICAL JOURNAL (2023)

Article Medicine, General & Internal

Multi-faceted intervention to improve management of antibiotics for children presenting to primary care with acute cough and respiratory tract infection (CHICO): efficient cluster randomised controlled trial

Peter S. Blair, Grace Young, Clare Clement, P. Dixon, Penny Seume, Jenny Ingram, Jodi Taylor, Christie Cabral, Patricia J. Lucas, Elizabeth Beech, Jeremy Horwood, Martin Gulliford, Nick A. Francis, Sam Creavin, Janet A. Lane, Scott Bevan, Alistair D Hay

Summary: This multifaceted intervention for children with respiratory tract infections in primary care did not reduce antibiotic dispensing or increase hospital admissions. However, there was some evidence that the intervention slightly reduced prescribing rates in certain subgroups and situations, but not in a clinically relevant way.

BMJ-BRITISH MEDICAL JOURNAL (2023)

Article Health Care Sciences & Services

Antibiotics for lower respiratory tract infection in children presenting in primary care: ARTIC-PC RCT

Paul Little, Nick A. Francis, Beth Stuart, Gilly O'Reilly, Natalie Thompson, Taeko Becque, Alastair Hay, Kay Wang, Michael Sharland, Anthony Harnden, Guiqing Yao, James Raftery, Shihua Zhu, Joseph Little, Charlotte Hookham, Kate Rowley, Joanne Euden, Kim Harman, Samuel Coenen, Robert C. Read, Catherine Woods, Christopher C. Butler, Saul N. Faust, Geraldine Leydon, Mandy Wan, Kerenza Hood, Jane Whitehurst, Samantha Richards-Hall, Peter Smith, Michael Thomas, Michael Moore, Theo Verheij

Summary: This study aims to evaluate the clinical effectiveness and cost-effectiveness of amoxicillin for uncomplicated lower respiratory tract infections in children. The results show that amoxicillin has no significant impact on clinical symptoms and resource utilization. It is suggested that parents and clinicians need better access to information and communication.

HEALTH TECHNOLOGY ASSESSMENT (2023)

Article Multidisciplinary Sciences

Determining the clinical and cost-effectiveness of nasal sprays and a physical activity and stress management intervention to reduce respiratory tract infections in primary care: A protocol for the 'Immune Defence' randomised controlled trial

Jane Vennik, Adam W. A. Geraghty, Kate Martinson, Lucy Yardley, Beth Stuart, Michael Moore, Nick Francis, Alastair Hay, Theo Verheij, Katherine Bradbury, Kate Greenwell, Laura Dennison, Sian Williamson, James Denison-Day, Ben Ainsworth, James Raftery, Shihua Zhu, Christopher Butler, Samantha Richards-Hall, Paul Little

Summary: Most adults in the UK experience viral respiratory tract infections (RTIs) annually, and certain individuals are at higher risk. Common nasal sprays and digital interventions promoting physical activity and stress management are being tested to reduce the incidence and severity of RTIs. This randomized controlled trial aims to compare the effectiveness and economic impact of these interventions. Recruitment started in December 2020 and is expected to be completed by April 2024.

PLOS ONE (2023)

Article Medicine, General & Internal

Shufeng Jiedu capsule for acute exacerbation of chronic obstructive pulmonary disease: a protocol of multicentre, randomised, double-blind, placebo-controlled trial

Ruyu Xia, Yutong Fei, Lishan Zhang, Zhijun Jie, Xiaoyun Fan, Mengyuan Dai, Michael Moore, Merlin Willcox, Xiaoyang Hu, Nick Francis, Changhao Liang, Guanghe Fei, Jianping Liu

Summary: This study aims to evaluate the effectiveness and safety of the Chinese patent herbal medicine Shufeng Jiedu capsule (SFJD) for treating acute exacerbations of chronic obstructive pulmonary disease (AECOPD). It is a multicentre, randomised, double-blind, placebo-controlled trial with 300 patients recruited in Beijing, Shanghai and Hefei. The primary outcome will be COPD symptom severity as measured by the EXAcerbation of Chronic Pulmonary Disease Tool score.

BMJ OPEN (2023)

Article Medicine, General & Internal

Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease

Oghenekome Gbinigie, Emma Ogburn, Julie Allen, Jienchi Dorward, Melissa Dobson, Tracie-Ann Madden, Ly-Mee Yu, David M. Lowe, Najib Rahman, Stavros Petrou, Duncan Richards, Kerenza Hood, Mahendra Patel, Benjamin R. Saville, Joe Marion, Jane Holmes, May Ee Png, Gail Hayward, Mark Lown, Victoria Harris, Bhautesh Jani, Nigel Hart, Saye Khoo, Heather Rutter, Jem Chalk, Joseph F. Standing, Judith Breuer, Layla Lavallee, Elizabeth Hadley, Lucy Cureton, Magdalena Benysek, Monique Andersson, Nick Francis, Nicholas P. B. Thomas, Philip Evans, Oliver van Hecke, Mona Koshkouei, Maria Coates, Sarah Barrett, Clare Bateman, Jennifer Davies, Ivy Raymundo-Wood, Andrew Ustianowski, Jonathan Nguyen-Van-Tam, Andrew Carson-Stevens, Richard Hobbs, Paul Little, Christopher C. Butler

Summary: This study is a clinical trial that aims to evaluate the safety, effectiveness, and cost-effectiveness of novel antiviral treatments for COVID-19 in vaccinated patients at increased risk in the community. It is an open-label, prospective, adaptive, multiarm platform trial that allows for the addition of new treatments and the evaluation of existing interventions. The study also includes a prospective economic evaluation.

BMJ OPEN (2023)

Article Pharmacology & Pharmacy

Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial

Merlin L. Willcox, Xiao-Yang Hu, Tom Oliver, Kerensa Thorne, Cherish Boxall, George He, Catherine Simpson, Becci Brotherwood, Alice O'Neil, Robert Waugh, Emma Tilt, Jeanne Trill, Neville Goward, Nick Francis, Michael Thomas, Paul Little, Tom Wilkinson, Jian-Ping Liu, Gareth Griffiths, Michael Moore

Summary: This study aimed to assess the feasibility of conducting a randomised placebo-controlled clinical trial of the Chinese herbal medicine Shufeng Jiedu (SFJD) for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in UK primary care. The results showed that the recruitment rate was lower than expected, possibly due to the lower incidence of AECOPD during the COVID-19 pandemic, patients starting antibiotics from rescue packs before seeing their GP, and challenges in the primary care workforce. However, the study was still able to demonstrate the feasibility of recruiting and randomising participants and identified approaches to address recruitment challenges.

FRONTIERS IN PHARMACOLOGY (2023)

Article Public, Environmental & Occupational Health

Best practice guidance for antibiotic audit and feedback interventions in primary care: a modified Delphi study from the Joint Programming Initiative on Antimicrobial resistance: Primary Care Antibiotic Audit and Feedback Network (JPIAMR-PAAN)

Kevin L. L. Schwartz, Alice X. T. Xu, Sarah Alderson, Lars Bjerrum, Jamie Brehaut, Benjamin C. C. Brown, Heiner C. C. Bucher, An De Sutter, Nick Francis, Jeremy Grimshaw, Ronny Gunnarsson, Sigurd Hoye, Noah Ivers, Donna M. M. Lecky, Morten Lindbaek, Jeffrey A. A. Linder, Paul Little, Benedikte Olsen Michalsen, Denise O'Connor, Celine Pulcini, Par-Daniel Sundvall, Pia Touboul Lundgren, Jan Y. Y. Verbakel, Theo J. J. Verheij

Summary: We have developed 13 best practice guidelines for designing and evaluating peer comparison audit and feedback on antibiotic prescribing in primary care. These guidelines can optimize the impact of quality improvement interventions and improve antibiotic prescribing in primary care.

ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2023)

No Data Available